Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07566338RecruitingPhase 1
Safety Study of LY4302814 in Healthy Adults
This is an early-stage study testing a new experimental medicine called LY4302814 in healthy volunteers to see if it is safe and how the body processes it. By enrolling healthy people first, researchers can understand the drug's basic safety profile before testing it in patients with medical conditions.
Daytona Beach, FloridaAges 18–65 - NCT07567872RecruitingPhase 1
Inhaled HRS-9821 Safety Study in Healthy People and COPD Patients
This is an early-stage study testing a new inhaled medication (HRS-9821) to see if it is safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with COPD (chronic lung disease) to understand if it might help with breathing.
Chengdu, SichuanAges 18–75 - NCT06249945RecruitingPhase 4
Empagliflozin for heart failure with preserved ejection fraction and dialysis
This trial tests whether a medicine called empagliflozin (used for diabetes and heart failure) can help people with both heart failure (with preserved pumping ability) and end-stage kidney disease who are on dialysis. The study looks at how the drug affects heart function and overall well-being.
HsinchuAges 20 years+ - NCT06252233Recruiting
Better quality of life with regular check-ins for lung cancer
This study tests whether having regular check-ins on your quality of life (like symptoms and daily well-being) can help you feel better during lung cancer treatment. It's for patients recently diagnosed with lung cancer who are getting care at select hospitals in Bavaria.
BambergAges 18 years+ - NCT07565493RecruitingEarly Phase 1
Psilocybin with a serotonin blocker in healthy adults
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
Baltimore, MarylandAges 21–60 - NCT07567040RecruitingPhase 3
Delaying Nearsightedness Onset in Children
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
Birmingham, AlabamaAges 6–11 - NCT07564947Enrolling by invitation
Reishi Mushroom for Fatty Liver Disease
This study tests whether Ganoderma lucidum (reishi mushroom) can improve liver health and reduce inflammation in people with fatty liver disease. Researchers will measure how it affects your liver function and antioxidant levels.
Peshawar, Khyber PakhtunkhwaAges 35–49 - NCT07560436RecruitingPhase 2
Stents for Heart Failure With Normal Pumping
This trial tests whether placing stents in coronary arteries helps patients with heart failure who still have a strong-pumping heart. The study aims to see if improving blood flow to the heart reduces symptoms and improves quality of life.
LondonAges 18 years+ - NCT07559656Recruiting
Oxytocin and Brain Training for Emotional Awareness
This study tests whether a nasal spray called oxytocin, combined with real-time brain imaging feedback, can help train a specific brain region involved in emotions and body awareness. Researchers will use MRI scans to show you your own brain activity in real time.
Chengdu, SichuanAges 18–30 - NCT07560878RecruitingEarly Phase 1
Brain Stimulation and Medication Study for Depression
This early-stage study tests a type of magnetic brain stimulation called theta burst stimulation combined with study medications to help treat moderate to severe depression. Researchers want to understand how this combination affects brain communication and may help reduce depressive symptoms.
Belmont, MassachusettsAges 18 years+ - NCT07563582Recruiting
Iron Supplement for Children with Celiac Disease and Low Iron
This study tests whether a special iron supplement taken by mouth helps children who have celiac disease (a condition where the body can't digest gluten) and low iron levels or anemia (not enough healthy red blood cells). The iron supplement is designed to be easily absorbed by the body.
Genova, ItalyAges 8–18 - NCT07563322Recruiting
Nicotinamide Riboside for Combined Pulmonary Hypertension
This study tests whether nicotinamide riboside (a B-vitamin supplement) can help people with combined pulmonary hypertension—a condition where blood pressure in the lungs is too high. The researchers want to understand how this supplement affects the body's energy metabolism and whether it might reduce symptoms and improve heart function.
Nashville, TennesseeAges 18–85 - NCT07568236RecruitingPhase 2
Fezolinetant for hot flushes in men on hormone therapy
This study tests whether fezolinetant can reduce hot flushes in men receiving hormone therapy (ADT) for prostate cancer. If you have bothersome hot flushes, this treatment may help lessen them.
ShatinAges 18 years+ - NCT07563439RecruitingPhase 2
PollenVax Shot for Mugwort Pollen Allergies
This study tests a new allergy shot (PollenVax) given under the skin to treat seasonal allergies caused by mugwort pollen. If you have moderate-to-severe mugwort allergies confirmed by testing, this trial may help reduce your symptoms during pollen season.
Almaty, AlmatyAges 18–65 - NCT07566351RecruitingPhase 2
Add-On Drugs for Rheumatoid Arthritis
This study tests whether two drugs—roflumilast and desloratadine—added to your current rheumatoid arthritis medications can reduce joint inflammation and pain. You'd take these as add-ons to your existing treatment to see if they help control your disease better.
Damietta, Damietta GovernorateAges 18–60 - NCT04920149RecruitingPhase 2
Mesalamine to help prevent colon cancer in Lynch syndrome
This trial tests whether mesalamine, a medicine used for bowel inflammation, can help prevent colorectal cancer in people with Lynch syndrome who do not currently have cancer. It may help by lowering the chance that new pre-cancer growths form over time.
AalborgAges 30 years+ - NCT06737549RecruitingPhase 4
Electroacupuncture and NGF for swallowing problems after stroke
This study tests whether a specific type of electroacupuncture (a gentle needle therapy with mild electrical pulses) plus a nerve growth factor injection can help people who have trouble swallowing after a recent stroke. The goal is to see if this combination improves swallowing function better than standard care.
Hangzhou, ZhejiangAges 18–80 - NCT06377761Recruiting
Qishen granules for heart failure with preserved pumping function
This trial tests a Chinese herbal medicine called Qishen Granules for people with heart failure who still have a normal pumping ability (ejection fraction 50% or higher). It may help reduce symptoms and improve heart function.
Guangzhou, GuangdongAges 18–85 - NCT06738329Recruiting
How seaweed additive carrageenan affects gut bacteria
This study tests whether carrageenan, a seaweed-based food ingredient, changes the balance of bacteria in your gut. It could help us understand how common food additives affect digestion and overall health.
Reading, ReadingAges 18–55 - NCT05772104RecruitingPhase 3
Test a Chinese herbal capsule for generalized anxiety
This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.
BeijingAges 18–65 - NCT05806346Recruiting
TXA dosing for heart surgery patients on bypass
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
SeoulAges 19 years+ - NCT07558642Recruiting
Nerve Block to Reduce Confusion in Older ICU Patients
This study tests whether a nerve-blocking injection (stellate ganglion block) can reduce confusion and help restore normal sleep-wake cycles in older adults staying in the intensive care unit. Researchers hope this treatment may help patients recover faster and feel more alert.
Antalya, MuratpaşaAges 65–99 - NCT07559500RecruitingPhase 1
Study of tirzepatide for alcohol use disorder
This trial tests if tirzepatide, a diabetes drug, affects brain chemistry linked to alcohol use. Researchers want to see if it can help people with mild-to-moderate alcohol use disorder who also have tried stimulants.
Bethesda, MarylandAges 21–65 - NCT06349980RecruitingPhase 2
Study of three drugs for liver cancer not yet treated
This trial is testing a combination of three drugs (HLX10, HLX04, and HLX53) to find the best dose and see if they help people with advanced liver cancer who have not had systemic treatment before. The goal is to shrink tumors and improve survival.
ShanghaiAges 18 years+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.